Compare GILT & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GILT | NPCE |
|---|---|---|
| Founded | 1987 | 1997 |
| Country | Israel | United States |
| Employees | 1159 | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 599.3M | 490.2M |
| IPO Year | 1997 | 2021 |
| Metric | GILT | NPCE |
|---|---|---|
| Price | $7.69 | $12.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $19.20 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 923.6K | 94.2K |
| Earning Date | 11-10-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $99,986,000.00 |
| Revenue This Year | $12.44 | $0.36 |
| Revenue Next Year | $11.62 | $22.05 |
| P/E Ratio | $42.82 | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $7.23 | $9.22 |
| 52 Week High | $20.99 | $19.60 |
| Indicator | GILT | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 33.84 | 39.89 |
| Support Level | $7.23 | N/A |
| Resistance Level | $10.39 | $15.26 |
| Average True Range (ATR) | 0.31 | 0.57 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 38.96 | 15.06 |
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company operates in three operating segments: Gilat Commercial Division, Gilat Defense Division, and Gilat Peru Division. The majority of its revenue is generated from the Gilat Commercial segment.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.